Research
Molecular
SCD1 inhibitors have been developed to treat various types of cancer.
SCD1 inhibitors could be a promising avenue for cancer therapy.
StrongSupportsmedium confidence
Potent SCD1 inhibitors have been developed to treat various types of cancer.
Why this rating
The abstract discusses advancements in SCD1 inhibitor development.
Source
SCD1 is the critical signaling hub to mediate metabolic diseases: Mechanism and the development of its inhibitors
Qin Sun et al. · Biomedicine & Pharmacotherapy · 2023
reviewCited 101×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →